Legacy medical equipment patching hits a 53% risk wall

AdvancedUNO
10 Jul, 2026
Legacy medical equipment patching hits a 53% risk wall

7 min read

The Economic Balance Sheet of Legacy Clinical Risk

  • The Patching Gap: The operational mismatch between 10-to-20-year clinical device lifecycles and modern, fast-moving cyber threat cycles.
  • The Cost Imbalance: Device manufacturers capture high upfront margins on capital sales, while hospital operating budgets absorb the compounding, multi-year cost of securing unpatchable operating systems.
  • The Regulatory Friction: Over half of currently active clinical IoT devices would fail the FDA's latest, more stringent cybersecurity standards if submitted for authorization today.
  • The Technical Constraint: Legacy devices are physically incapable of supporting modern encryption or operating system updates, forcing hospitals to build expensive network-level workarounds.
  • The Clinical Cost: When vulnerabilities are exploited, the cost is measured not in ransom payments, but in diverted ambulances, canceled surgeries, and delayed clinical services.

Why Are Hospitals Left Holding the Bill for Unpatchable Devices?

How did healthcare facilities become the primary financial backstop for medical devices that cannot support basic security patches? In April 2025, during a hearing before the House Committee on Energy and Commerce, cybersecurity expert Kevin Fu described the state of legacy medical devices as akin to "driving a car built without a seat belt." It is a quiet, systemic failure of incentives: medical device manufacturers pocket the profits from selling long-lived clinical hardware, while hospital IT departments are left to absorb the escalating costs of defending devices that are fundamentally unpatchable.

To understand this crisis, one must look at the divergence between clinical utility and software decay. A high-end magnetic resonance imaging (MRI) machine or a linear accelerator is built to last 15 to 20 years. Its mechanical, magnetic, and radiological components perform as flawlessly in year 15 as they did on day one. But the embedded operating system underneath—often a stripped-down version of Windows or an obsolete real-time operating system—reaches its end-of-life within five years. The hardware remains a pristine clinical asset, while the software becomes a toxic security liability.

This is not a theoretical compliance problem; it is an active operational drain. When 53% of connected medical devices and other hospital IoT hardware harbor known critical vulnerabilities, the clinical workflow is constantly exposed. If an adversary exploits an unpatched vulnerability in an infusion pump fleet, the immediate response is not a simple software update. It is the physical removal of those pumps from patient bedside service, a disruption that directly impacts patient care and device availability.

The Friction of the Slow Migration to Secure Architecture

We are not witnessing a sudden, clean transition to modern secure-by-design medical devices. Instead, healthcare is stuck in a painful, decades-long, half-finished migration. Device manufacturers have historically treated cybersecurity as an afterthought, shipping systems with hardcoded credentials and unencrypted protocols. To upgrade these fleets, hospitals cannot simply force a software update. In many cases, the physical hardware lacks the memory or processing power to run modern TLS encryption or host-based security agents.

Legacy clinical equipment is like an old municipal water system where you cannot patch individual leaking pipes without digging up the entire city, so you are forced to build expensive external filtration basins instead. Rather than fixing the device itself, hospital network engineers must build complex, external digital fortresses around each piece of vulnerable hardware. This shift moves the financial and operational burden entirely from the manufacturer's engineering team to the hospital's network operations center.

The Illusion of the "Unpatchable" Device

The term "legacy" is frequently misunderstood. It does not merely refer to decades-old machines gathering dust in a basement. A legacy device can be a brand-new system purchased last year that was designed with outdated dependencies or lack of support for modern encryption standards. When the FDA issues new, stringent cybersecurity guidelines, they apply to new submissions, leaving the millions of active devices already deployed in the field completely untouched by these regulatory safety nets.

"We are trying to secure a 21st-century clinical network using defensive strategies designed for 1990s desktop computers."

The Economic Disparity of Device Security

The financial asymmetry between medical device manufacturers (OEMs) and healthcare delivery organizations (HDOs) is stark. The following table highlights where the economic value is captured and where the security costs are quietly absorbed under the current legacy paradigm.

Security Dimension Device Manufacturer (OEM) Reality Hospital (HDO) Reality
Revenue Capture High upfront margins on capital sales; lucrative proprietary service contracts. Low-margin clinical reimbursement rates; rising insurance premiums.
Software Maintenance Charges premium fees for software upgrades; deprecates support after 5–7 years. Must pay for upgrades or accept the risk of running unsupported operating systems.
Risk Ownership Shielded by liability waivers; limits responsibility to "intended clinical use." Absorbs full liability for patient safety, data breaches, and HIPAA violations.
Mitigation Costs Minimal; rarely retrofits legacy fleets with modern security controls. High; must purchase microsegmentation tools, firewalls, and monitoring software.

The True Cost of Microsegmentation on a 60,000-Device Network

To understand the sheer scale of the operational burden, consider the reality of a modern regional health system. When Main Line Health tackled the security of its network, they had to manage more than 60,000 connected devices. Securing a fleet of this size cannot be achieved by waiting for vendor patches that will never arrive. It requires a systematic, resource-intensive deployment of network microsegmentation.

  1. Passive Traffic Profiling: Before a single security rule can be written, the security team must deploy passive monitoring tools (such as Medigate, Armis, or Claroty) to discover every connected device. This phase often reveals hundreds of undocumented systems, from legacy physiological monitors to smart refrigerators, communicating over unencrypted protocols.
  2. Clinical Policy Negotiation: The security team must work closely with clinical operations to map device workflows. As Aaron Weismann, CISO of Main Line Health, noted, walking into a clinical space and announcing you are going to prevent devices from talking to each other is incredibly disruptive. A single misconfigured network rule could block a critical telemetry feed during a cardiac event.
  3. VLAN and Firewall Orchestration: Engineers must write and maintain thousands of custom Access Control Lists (ACLs) on core switches and firewalls. This creates a permanent operational tax, as every new device purchase or software update requires manual modification of network policies to prevent clinical downtime.

The Misunderstood Realities of Clinical Network Defense

  • The Myth of the Air-Gapped Network: Many clinical leaders believe that critical devices are safe because they are "isolated" from the internet. In reality, modern radiology suites, laboratory analyzers, and patient monitors must constantly communicate with the Electronic Health Record (EHR) system, PACS servers, and remote vendor diagnostics portals, completely obliterating any true air gap.
  • The Myth of Vendor Software Support: It is widely assumed that medical device service contracts guarantee cybersecurity protection. Most contracts only cover hardware maintenance and basic software bug fixes, explicitly excluding the labor and licensing costs required to upgrade an underlying operating system to a secure version.
  • The Myth of the Pure Software Solution: Security vendors often pitch software-defined networks as a silver bullet for legacy risk. No software tool can fix a legacy device that lacks the physical memory to process modern cryptographic certificates, meaning some level of operational risk must always be accepted and manually managed.

The Case for Managed Obsolescence Over Forced Replacement

A hospital cannot simply scrap a $2 million CT scanner because its onboard computer runs an unpatched version of Windows. In the real world, we must practice the art of managed obsolescence. This means accepting that certain clinical assets will remain vulnerable, and instead focusing our limited resources on minimizing their blast radius. By combining strict physical access controls, dedicated virtual local area networks (VLANs), and protocol-specific gateways, we can safely sweat these legacy assets until their clinical lifecycle naturally ends.

Ultimately, the long-term solution requires a fundamental shift in how medical devices are procured. Health systems must use their purchasing power to demand contract terms that hold manufacturers financially responsible for security updates throughout the entire expected clinical lifespan of the device. Until we stop buying devices built without seat belts, we will continue to pay a premium to build our own guardrails.

Frequently Asked Questions

What happens to our clinical risk posture when a medical device manufacturer goes bankrupt or deprecates a product line?

When an OEM goes bankrupt or ends support, the device instantly becomes an unpatchable "orphan." The hospital's security team must take full ownership of the device's risk. This requires isolating the orphan device on a dedicated, non-routing VLAN, disabling all unused physical ports, and implementing strict firewall rules that only allow communication with specific, trusted internal IP addresses.

Why can't we simply install enterprise endpoint detection and response (EDR) agents on legacy imaging workstations?

Installing third-party software like CrowdStrike or SentinelOne on a medical device is generally prohibited by manufacturers and can void the device's FDA clearance or warranty. Furthermore, legacy workstations often run on highly constrained hardware where the resource overhead of an EDR agent could cause the clinical application to freeze or crash during a patient procedure.

How do we handle the FDA's latest cybersecurity guidelines when upgrading legacy systems that were originally certified under older regulatory frameworks?

The FDA's newest cybersecurity requirements primarily apply to new premarket submissions. However, if a hospital performs a significant modification to an existing device that alters its intended use or clinical software pipeline, it may trigger a new regulatory review, forcing the system to meet modern security standards. For routine maintenance, hospitals must rely on compensating network controls rather than trying to force the device into modern compliance.

Related from this blog

Sources

Next Post Previous Post
No Comment
Add Comment
comment url